Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Naporafenib and Trametinib Combination to Other Therapies for Patients with Previously Treated Unresectable or Metastatic NRAS Mutant Melanoma
Not recruiting
Investigated Diseases:Investigated Drugs:
+4
Study on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
Not recruiting
Investigated Drugs:
+2
Study on Atezolizumab and Tiragolumab for Patients with Head and Neck Cancer, Metastatic Melanoma, and Other Advanced Solid Tumors
Not recruiting
Investigated Diseases:Investigated Drugs:
